Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$197K Hold
362
﹤0.01% 2726
2026
Q1
$157K Buy
362
+290
+403% +$128K ﹤0.01% 2777
2025
Q4
$23.6K Buy
+72
New +$23.1K ﹤0.01% 2718
2025
Q3
Sell
-27,171
Closed -$7.48M 2488
2025
Q2
$7.48M Buy
27,171
+10,142
+60% +$2.06M ﹤0.01% 1501
2025
Q1
$3.14M Sell
17,029
-12,091
-42% -$2.79M ﹤0.01% 1792
2024
Q4
$5.74M Buy
29,120
+307
+1% +$59K ﹤0.01% 1539
2024
Q3
$6M Sell
28,813
-1,710
-6% -$365K ﹤0.01% 1470
2024
Q2
$7.16M Buy
+30,523
New +$6.04M ﹤0.01% 1289

Other funds holding NVMI

UBS AM's NVMI Position: Q2 2026 in Review

UBS AM held its Nova (NVMI) position steady in Q2 2026 at 362 shares worth $197K. The position accounts for ﹤0.01% of the portfolio, ranked #2726.

UBS AM first reported a position in NVMI in Q2 2024 and has held it in 8 quarters since. The position peaked at $7.48M in Q2 2025. 345 funds tracked by Wall St. Rank hold NVMI as of Q2 2026.

  • UBS AM held 362 shares of Nova worth $197K as of Q2 2026.
  • UBS AM left its Nova share count unchanged in Q2 2026.
  • Nova made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2726 holding.
  • UBS AM first reported a position in Nova in Q2 2024 and has held it in 8 quarters since.
  • UBS AM's Nova position peaked at $7.48M in Q2 2025.
  • 345 funds tracked by Wall St. Rank held Nova as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.